COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 15:05, il y a 11 mois 8 jours True Global Ventures celebrates two major portfolio milestones in 72 hours, marking a defining moment in the U.S. True Global Ventures celebrates two major portfolio milestones in the U.S. with Forge Global's $660 million acquisition by Charles Schwab and Animoca Brands' planned Nasdaq listing through Currenc Group Inc Private Markets True Global Ventures Forge Global Animoca Brands Portfolio Milestones
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 15:04, il y a 11 mois 8 jours Notice of satisfaction of financing condition and make-whole redemption amount CPI Property Group satisfies financing condition for make-whole redemption of senior notes due May 2026, announces 100.178% redemption amount CPI Property Group Senior Notes Make-whole Redemption Financing Condition Redemption Amount
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:55, il y a 11 mois 8 jours METLEN Transformation: The Third Era - Progress in Motion METLEN announces the launch of its third strategic transformation, 'The Third Era - Progress in Motion,' introducing key leadership changes and organizational restructuring for future growth Leadership Changes Growth Strategic Transformation Organizational Restructuring METLEN
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:53, il y a 11 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. files Form 8.3 disclosing ownership of 10.63% of Qualcomm Incorporated's relevant securities Form 8.3 Relevant Securities The Vanguard Group Ownership Disclosure Qualcomm Incorporated
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:52, il y a 11 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as of 10 Nov 2025 Securities The Vanguard Group, Inc. Disclosure Stake American Axle
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:51, il y a 11 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.67% stake in Avadel Pharmaceuticals plc as of 10 Nov 2025. Form 8.3 submitted to Irish Takeover Panel The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:50, il y a 11 mois 8 jours ACCESS Newswire Reports Third Quarter 2025 Results ACCESS Newswire Inc. (NYSE: ACCS) reports Q3 2025 revenue at $5.7M, a 2% increase YoY. Adjusted EBITDA rises 71% to $933,000 YoY. Gross margin remains strong at 75% Adjusted EBITDA Gross Margin ACCESS Newswire Q3 2025 Revenue NYSE: ACCS
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:49, il y a 11 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses owning 5.38% of Just Group plc's 10p ordinary shares as of 10/11/2025. Details in Form 8.3 Securities Form 8.3 Disclosure The Vanguard Group Just Group Plc
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:48, il y a 11 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc The Vanguard Group, Inc. discloses a 2.17% stake in Wood Group (John) plc. Sale of 10,532,011 shares at 0.24 GBP per share on 10-Nov-2025 The Vanguard Group Financial Disclosure Stake Disclosure Share Sale Wood Group (John) PLC
COMMUNIQUÉ DE PRESSE publié le 11/11/2025 à 14:45, il y a 11 mois 8 jours Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025 Dogwood Therapeutics reports low early termination rate in ongoing HALT-CINP Phase 2b trial for Halneuron® vs placebo in cancer patients with chemotherapy-induced neuropathy. Recruitment on track with 100 patients enrolled for study evaluation Clinical Trial Dogwood Therapeutics Halneuron® HALT-CINP Chemotherapy-induced Neuropathic Pain
Publié le 19/10/2026 à 19:00, il y a 1 heure 50 minutes COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Publié le 19/10/2026 à 18:40, il y a 2 heures 10 minutes Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Publié le 19/10/2026 à 18:40, il y a 2 heures 10 minutes Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Publié le 19/10/2026 à 18:00, il y a 2 heures 50 minutes WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Publié le 19/10/2026 à 18:00, il y a 2 heures 50 minutes L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
Publié le 19/10/2026 à 14:30, il y a 6 heures 20 minutes Core Silver Intersects Copper Bearing VMS Mineralization at the Touleary Project
Publié le 19/10/2026 à 14:00, il y a 6 heures 50 minutes Four Nines Gold Intersects 80.1 Meters Averaging 1.08 g/t Gold in Expanding Lower Telegraph Corridor at Hayden Hill
Publié le 19/10/2026 à 13:30, il y a 7 heures 20 minutes Empress Announces Closing of Tongon Gold Stream Investment and Debt Financing
Publié le 19/10/2026 à 13:30, il y a 7 heures 20 minutes Mako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albino
Publié le 19/10/2026 à 13:01, il y a 7 heures 49 minutes CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Publié le 19/10/2026 à 19:00, il y a 1 heure 50 minutes PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Publié le 19/10/2026 à 18:05, il y a 2 heures 45 minutes Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Publié le 19/10/2026 à 17:45, il y a 3 heures 5 minutes VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Publié le 19/10/2026 à 17:45, il y a 3 heures 5 minutes VALBIOTIS SA: Valbiotis doublement récompensé « Meilleur Produit Pharma 2027 » pour ses solutions ValbiotisPRO® Cholestérol et ValbiotisPRO® Santé Métabolique
Publié le 19/10/2026 à 17:30, il y a 3 heures 20 minutes GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 19/10/2026